GO:0055070 copper ion homeostasis: Regulation, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0055070 copper ion homeostasis is defined as any process involved in the maintenance of an internal steady state of copper ions within an organism or cell.
• Copper is an essential trace metal that serves as a catalytic cofactor for enzymes involved in respiration, antioxidant defense, and neurotransmitter synthesis, but free copper is toxic and must be tightly buffered [2,3].
• Disrupted copper homeostasis is implicated in cancer, liver diseases, and neurodegenerative disorders such as Alzheimer's and Parkinson's diseases [1,5,6].
• Cuproptosis, a copper-dependent form of regulated cell death, links copper homeostasis to cancer immunotherapy and provides a therapeutic target [1,5].
• Key genes controlling copper homeostasis include ATP7A, ATP7B, SLC31A1 (CTR1), ATOX1, CCS, SOD1, MT1A, and CP, which regulate copper uptake, distribution, and efflux [2,5].
• CRISPR-based knockout, knock-in, and overexpression models are powerful tools to dissect causal roles of copper homeostasis genes in disease and to screen for modulators of cuproptosis [1,8].
Description
Copper ion homeostasis (GO:0055070) refers to the biological processes that maintain the internal steady state of copper ions within an organism or cell. Copper is an essential micronutrient that acts as a cofactor for key enzymes such as cytochrome c oxidase, superoxide dismutase 1 (SOD1), and ceruloplasmin (CP), but its redox activity also makes it potentially toxic when unbound [2,3]. Therefore, cells have evolved sophisticated transport and buffering systems to ensure adequate copper supply while preventing oxidative damage [2,5]. Understanding copper ion homeostasis is critical for researchers because its dysregulation is increasingly linked to cancer, liver disorders, and neurodegenerative diseases [1,5,6]. Moreover, the discovery of cuproptosis, a copper-dependent cell death pathway, has opened new avenues for cancer therapy and immunotherapy [1,5]. This article provides a research-grade overview of the ontology, mechanisms, key genes, and experimental models used to study copper ion homeostasis.
copper ion homeostasis At A Glance
| GO ID | GO:0055070 |
|---|---|
| GO term | copper ion homeostasis |
| Ontology | biological_process |
| Synonym | copper homeostasis |
| Major function | Maintenance of internal steady state of copper ions within an organism or cell |
| Related diseases | Cancer, liver diseases, neurodegenerative disorders, Menkes and Wilson diseases [1,5,6] |
| Key regulators | ATP7A, ATP7B, SLC31A1, ATOX1, CCS, SOD1, MT1A, CP [2,5] |
| Therapeutic relevance | Target for cuproptosis induction in cancer immunotherapy [1,5] |
What Is GO:0055070?
According to the Gene Ontology, copper ion homeostasis (GO:0055070) is any process involved in the maintenance of an internal steady state of copper ions within an organism or cell. This includes the regulation of copper uptake, intracellular trafficking, sequestration by metallothioneins, and efflux to prevent both deficiency and overload [2,5]. The term is a biological process that encompasses molecular functions such as copper ion binding, transport, and chaperone activity, and it is essential for normal physiology and disease prevention [2,3].
Why Is copper ion homeostasis Important in Cell Biology?
Copper ion homeostasis is vital because copper is both essential and toxic; insufficient copper impairs mitochondrial respiration and antioxidant defense, while excess free copper catalyzes reactive oxygen species (ROS) production and damages lipids, proteins, and DNA [2,3]. Consequently, disturbances in copper balance contribute to a wide range of human pathologies, including cancer, liver diseases, and neurodegeneration [1,5,6]. Studying the mechanisms that maintain copper homeostasis provides insights into disease pathogenesis and identifies potential therapeutic targets, such as cuproptosis inducers for cancer treatment [1,5].
• Copper is a cofactor for enzymes involved in energy metabolism, iron oxidation, and neurotransmitter synthesis.
• Copper dysregulation leads to oxidative stress and is implicated in Alzheimer's and Parkinson's diseases.
• Cuproptosis, a copper-dependent cell death, is a novel target for cancer therapy.
• Wilson disease and Menkes disease are caused by mutations in copper-transporting ATPases ATP7B and ATP7A, respectively.
• Copper homeostasis influences immune responses and can be modulated to enhance immunotherapy [1,4].
• Metallothioneins and glutathione buffer intracellular copper to prevent toxicity.
• Copper is required for angiogenesis and tumor growth, making it a target in oncology.
• Model organisms such as C. elegans provide conserved insights into copper homeostasis mechanisms.
What Happens During copper ion homeostasis?
Copper Uptake and Intracellular Transport
In simple terms: Cells take in copper from the outside and move it to where it is needed.
Copper enters cells primarily through the high-affinity copper transporter SLC31A1 (CTR1) and is then delivered to intracellular targets by copper chaperones such as ATOX1, CCS, and COX17 [2,5]. ATOX1 transports copper to the trans-Golgi network for incorporation into copper-dependent enzymes and for efflux via ATP7A/ATP7B. This tightly regulated uptake and distribution ensure that copper reaches essential cuproenzymes without accumulating in toxic forms.
Copper Sequestration and Buffering
In simple terms: Excess copper is captured by special proteins to keep it harmless.
Metallothioneins (MT1A, MT2A) and glutathione bind copper with high affinity, preventing free copper from participating in Fenton-like reactions that generate ROS [2,3]. This buffering capacity is critical for maintaining redox balance and protecting cells from oxidative damage. The expression of metallothioneins is regulated by metal-responsive transcription factor 1 (MTF1) in response to copper levels.
Copper Efflux and Systemic Balance
In simple terms: Cells pump out extra copper to keep the right amount inside.
When intracellular copper exceeds cellular needs, ATP7A and ATP7B translocate to membranes and export copper out of the cell or into secretory vesicles. In hepatocytes, ATP7B is essential for biliary copper excretion and for loading ceruloplasmin with copper. Defects in these transporters cause copper accumulation (Wilson disease) or copper deficiency (Menkes disease).
Copper-Dependent Cell Death (Cuproptosis)
In simple terms: Too much copper can trigger a specific type of cell death called cuproptosis.
Excessive intracellular copper binds to lipoylated enzymes of the tricarboxylic acid (TCA) cycle, leading to protein aggregation and cell death termed cuproptosis [1,5]. This process is distinct from apoptosis and depends on mitochondrial respiration. Targeting copper homeostasis to induce cuproptosis is being explored as a strategy to enhance cancer immunotherapy [1,4].
Key Genes Involved in GO:0055070 copper ion homeostasis
The following genes encode proteins that directly participate in copper uptake, distribution, sequestration, efflux, and copper-dependent processes.
| Gene | Major Role | Research Relevance |
|---|---|---|
| SLC31A1 (CTR1) | High-affinity copper uptake transporter | Knockout reduces copper uptake and affects cuproptosis sensitivity [2,5] |
| ATP7A | Copper efflux pump; mutations cause Menkes disease | Knockout models show copper accumulation and neurodegeneration |
| ATP7B | Copper efflux pump; mutations cause Wilson disease | Knockout models develop hepatic copper overload |
| ATOX1 | Copper chaperone delivering copper to ATP7A/B | Knockdown alters copper distribution and efflux |
| CCS | Copper chaperone for SOD1 | Knockout affects SOD1 maturation and oxidative stress response |
| SOD1 | Copper-zinc superoxide dismutase; antioxidant enzyme | Mutations linked to amyotrophic lateral sclerosis |
| MT1A | Metallothionein; copper sequestration | Overexpression protects against copper toxicity |
| MT2A | Metallothionein; copper buffering | Modulates intracellular copper availability |
| CP | Ceruloplasmin; copper transport in blood | Knockout leads to iron and copper dyshomeostasis |
| COX17 | Copper chaperone for cytochrome c oxidase | Knockdown impairs mitochondrial respiration |
| SCO1 | Copper chaperone for cytochrome c oxidase assembly | Mutations cause mitochondrial dysfunction |
| MTF1 | Metal-responsive transcription factor | Regulates metallothionein and other copper genes |
| COMMD1 | Involved in copper excretion and ATP7B regulation | Knockdown affects hepatic copper balance |
| XIAP | Regulates copper homeostasis and cuproptosis | Knockout sensitizes cells to copper-induced death |
| FDX1 | Ferredoxin 1; required for cuproptosis | Knockout confers resistance to cuproptosis |
| DLAT | Dihydrolipoamide S-acetyltransferase; lipoylated target | Knockout prevents copper-induced aggregation |
| LIAS | Lipoyl synthase; required for cuproptosis | Knockout reduces cuproptosis sensitivity |
| SLC25A3 | Mitochondrial copper transporter | Knockdown affects cytochrome c oxidase activity |
How Is copper ion homeostasis Regulated?
Copper ion homeostasis is regulated at multiple levels. The metal-responsive transcription factor MTF1 controls the expression of metallothioneins and other copper-handling genes in response to intracellular copper levels. Additionally, the copper chaperone ATOX1 delivers copper to ATP7A/ATP7B, which undergo copper-dependent trafficking to modulate efflux. Recent studies have linked copper homeostasis to cuproptosis, where mitochondrial respiration and lipoylation of TCA cycle enzymes determine sensitivity to copper-induced cell death. Furthermore, systemic copper balance is influenced by dietary intake and hepatic excretion, with ceruloplasmin playing a key role in copper transport in the bloodstream.
copper ion homeostasis and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| ATP7B | Wilson disease; hepatic copper overload | Knockout hepatocyte cell lines; point mutation knock-in |
| ATP7A | Menkes disease; copper deficiency | Knockout neuronal cells; overexpression of wild-type ATP7A |
| SOD1 | Amyotrophic lateral sclerosis; oxidative stress | Point mutation knock-in (e.g., G93A) in motor neurons |
| FDX1 | Cuproptosis sensitivity in cancer | Knockout cancer cell lines; overexpression for resistance |
| DLAT | Cuproptosis; protein aggregation | Knockout or point mutation of lipoylation sites |
Copper Homeostasis in Cancer and Cuproptosis
Cancer cells often reprogram copper metabolism to support proliferation and angiogenesis. However, excessive copper can trigger cuproptosis, a novel form of cell death that is being exploited for cancer therapy. Modulating copper homeostasis to induce cuproptosis has been shown to enhance breast cancer immunotherapy in preclinical models. Bimetallic peroxide nanoparticles that disrupt ion homeostasis can induce PANoptosis and improve immunotherapy outcomes.
Copper Dysregulation in Liver Diseases
The liver is central to systemic copper homeostasis, and mutations in ATP7B cause Wilson disease, characterized by hepatic copper accumulation and liver damage. Mechanisms of copper metabolism and cuproptosis are implicated in various liver diseases, including hepatocellular carcinoma and non-alcoholic fatty liver disease. Targeting copper homeostasis pathways may offer therapeutic strategies for these conditions.
Copper and Neurodegenerative Disorders
Copper imbalance is observed in Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis (ALS). Copper binding to amyloid-beta and alpha-synuclein promotes aggregation and oxidative stress, contributing to neurodegeneration. Mutations in SOD1, a copper-dependent enzyme, are linked to familial ALS. Maintaining copper homeostasis is therefore a potential therapeutic approach for neurodegenerative diseases.
From copper ion homeostasis-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of SLC31A1 affect copper uptake and cuproptosis? | Knockout cell line (e.g., HEK293T, HeLa) |
| Does a specific ATP7B mutation cause Wilson disease phenotypes? | Point mutation knock-in in hepatocytes or iPSCs |
| Can overexpression of MT1A protect against copper toxicity? | Overexpression cell model (e.g., neuronal cells) |
| How does copper binding to alpha-synuclein affect aggregation? | Knock-in of copper-binding mutations in alpha-synuclein |
| What is the role of FDX1 in cuproptosis? | Knockout and rescue with tagged FDX1 |
| Does ATP7A trafficking respond to copper levels? | Tagged knock-in of ATP7A with fluorescent protein |
How to Study the copper ion homeostasis Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Global gene expression changes | Identify copper-responsive pathways |
| CRISPR library screening | Gene essentiality and copper sensitivity | Discover regulators of cuproptosis |
| ICP-MS | Intracellular copper and metal content | Quantify copper accumulation in knockout cells |
| Live-cell imaging with copper sensors | Labile copper pools and dynamics | Monitor real-time copper flux |
| Seahorse assay | Mitochondrial respiration | Assess metabolic impact of copper stress |
| Western blot | Protein expression and lipoylation | Validate cuproptosis markers |
| Immunofluorescence | Protein localization and trafficking | Study ATP7A/B translocation |
| C. elegans genetics | Conserved copper homeostasis | Screen for modifiers of copper toxicity |
Genomic and Transcriptomic Approaches
RNA-seq and microarray analyses can identify global changes in gene expression upon modulation of copper levels or genetic perturbation of copper homeostasis genes. CRISPR library screening enables unbiased discovery of genes that regulate copper sensitivity or cuproptosis. These methods help pinpoint pathways and networks controlled by copper homeostasis.
Proteomic and Metallomic Profiling
Proteomics can assess changes in copper-binding proteins and metallothionein levels, while metallomics using ICP-MS quantifies intracellular copper and other metals. These techniques are essential to validate copper-dependent phenotypes and to measure the efficacy of genetic modifications.
Imaging and Functional Assays
Fluorescent copper sensors (e.g., CS3) and live-cell imaging allow real-time monitoring of labile copper pools. Functional assays such as MTT, ROS detection, and mitochondrial respiration measurements (Seahorse) assess the impact of copper homeostasis on cell viability and metabolism [1,5].
Animal Models and Organoids
Mouse models with knockout or knock-in of copper homeostasis genes (e.g., Atp7b-/-) recapitulate human diseases and provide systemic insights. Organoids derived from patient iPSCs can model tissue-specific copper handling and drug responses. The nematode C. elegans is a powerful model for conserved copper homeostasis mechanisms.
How CRISPR Can Be Used to Study GO:0055070 copper ion homeostasis
Knockout
CRISPR knockout of copper homeostasis genes such as SLC31A1, ATP7A, or ATP7B in cell lines provides a direct way to study loss-of-function phenotypes, including altered copper uptake, efflux, and sensitivity to cuproptosis inducers [1,5]. Knockout models are also used in genome-wide screens to identify novel regulators of copper homeostasis.
Point Mutation
Point mutation knock-in using CRISPR can replicate disease-associated mutations, such as those in ATP7B (Wilson disease) or SOD1 (ALS), to study their effects on protein function and copper handling [5,6]. These models are valuable for testing allele-specific therapies and understanding genotype-phenotype relationships.
Knock-in
Knock-in of tagged versions of copper transporters (e.g., ATP7A-GFP) allows real-time tracking of protein localization and trafficking in response to copper levels. Knock-in of reporter genes under the control of copper-responsive promoters (e.g., MT1A) enables sensitive detection of copper status.
Overexpression
Overexpression of copper chaperones (e.g., ATOX1) or metallothioneins (e.g., MT1A) can protect cells from copper toxicity and modulate cuproptosis sensitivity [2,5]. Overexpression models are useful for gain-of-function studies and for validating therapeutic targets.
How EDITGENE Supports copper ion homeostasis Research
Researchers studying copper ion homeostasis-related genes often need to determine whether a candidate gene is causally involved in copper handling, disease progression, or therapeutic response. Generating precise genetic models is essential to establish causality and to validate potential drug targets. EDITGENE provides a comprehensive suite of CRISPR-based services to accelerate this research.
Contact EDITGENE today to design your custom CRISPR model for copper ion homeostasis research.
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| CUTC Knockout HEK293 Cell Line | EDJ-KQ10906 | Human | 51076 | Details Get a Quote |
| COMMD1 Knockout HEK293 Cell Line | EDJ-KQ11308 | Human | 150684 | Details Get a Quote |
| XIAP Knockout HEK293 Cell Line | EDJ-KQ17915 | Human | 331 | Details Get a Quote |
| XIAP Knockout A-549 Cell Line | EDJ-KQ19058 | Human | 331 | Details Get a Quote |
| XIAP Knockout HCT 116 Cell Line | EDJ-KQ19059 | Human | 331 | Details Get a Quote |
| XIAP Knockout HeLa Cell Line | EDJ-KQ19060 | Human | 331 | Details Get a Quote |
| CUTC Knockout HeLa Cell Line | EDJ-KQ37334 | Human | 51076 | Details Get a Quote |
| CUTC Knockout A-549 Cell Line | EDJ-KQ38630 | Human | 51076 | Details Get a Quote |
| CUTC Knockout HCT 116 Cell Line | EDJ-KQ38631 | Human | 51076 | Details Get a Quote |
| COMMD1 Knockout A-549 Cell Line | EDJ-KQ39437 | Human | 150684 | Details Get a Quote |
| COMMD1 Knockout HCT 116 Cell Line | EDJ-KQ39438 | Human | 150684 | Details Get a Quote |
| COMMD1 Knockout HeLa Cell Line | EDJ-KQ39439 | Human | 150684 | Details Get a Quote |
Displaying Records 1 To 12 Of 12 Records
Frequently Asked Questions About copper ion homeostasis
What is copper ion homeostasis?
Copper ion homeostasis (GO:0055070) is the biological process that maintains the internal steady state of copper ions within an organism or cell, ensuring adequate copper for essential enzymes while preventing toxicity.
What genes are involved in copper ion homeostasis?
Key genes include SLC31A1 (CTR1), ATP7A, ATP7B, ATOX1, CCS, SOD1, MT1A, MT2A, CP, COX17, SCO1, MTF1, COMMD1, FDX1, DLAT, LIAS, and SLC25A3 [2,5].
How does copper homeostasis relate to cancer?
Cancer cells often alter copper metabolism to support growth, and inducing copper-dependent cell death (cuproptosis) is a promising therapeutic strategy, especially in immunotherapy [1,4].
What is cuproptosis?
Cuproptosis is a copper-dependent form of regulated cell death triggered by excessive intracellular copper binding to lipoylated TCA cycle enzymes, leading to protein aggregation and cell death [1,5].
Which diseases are linked to copper imbalance?
Copper imbalance is linked to Wilson disease, Menkes disease, Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, and various cancers [5,6].
How can I study copper ion homeostasis in the lab?
Common methods include CRISPR knockout/knock-in, RNA-seq, ICP-MS, live-cell imaging with copper sensors, and functional assays such as Seahorse and ROS detection [1,2,5].
What is the role of ATP7B in copper homeostasis?
ATP7B is a copper-transporting ATPase that exports excess copper from hepatocytes and loads ceruloplasmin; mutations cause Wilson disease.
What is the role of SLC31A1 (CTR1)?
SLC31A1 is the primary high-affinity copper importer that mediates cellular copper uptake; its knockout reduces intracellular copper and affects cuproptosis sensitivity [2,5].
How does copper contribute to neurodegeneration?
Copper can bind to amyloid-beta and alpha-synuclein, promoting aggregation and oxidative stress, which contribute to Alzheimer's and Parkinson's diseases [6,7].
What CRISPR services are available for copper homeostasis research?
EDITGENE offers knockout, point mutation knock-in, tagged knock-in, overexpression cell models, CRISPR library screening, and bioinformatics services for copper homeostasis genes [1,5].
Conclusion
Copper ion homeostasis (GO:0055070) is a fundamental biological process that balances the essential yet toxic nature of copper. Its dysregulation is implicated in a growing list of human diseases, from cancer to neurodegeneration, and the emerging concept of cuproptosis has opened new therapeutic avenues [1,5,6]. Understanding the genes and mechanisms controlling copper homeostasis is therefore critical for both basic research and drug development. EDITGENE provides comprehensive CRISPR solutions to study these processes with precision and efficiency.
References
- 1. Guan M et al.. 2024. Regulating copper homeostasis of tumor cells to promote cuproptosis for enhancing breast cancer immunotherapy.. Nat Commun 15(1):10060 PMID: 39567558
- 2. Jomova K et al.. 2022. Essential metals in health and disease.. Chem Biol Interact 367:110173 PMID: 36152810
- 3. Martín Giménez VM et al.. 2021. Metal ion homeostasis with emphasis on zinc and copper: Potential crucial link to explain the non-classical antioxidative properties of vitamin D and melatonin.. Life Sci 281:119770 PMID: 34197883
- 4. Hou G et al.. 2024. Bimetallic peroxide nanoparticles induce PANoptosis by disrupting ion homeostasis for enhanced immunotherapy.. Sci Adv 10(45):eadp7160 PMID: 39514658
- 5. Chen H et al.. 2025. Mechanisms of copper metabolism and cuproptosis: implications for liver diseases.. Front Immunol 16:1633711 PMID: 40808953
- 6. Chen L et al.. 2025. Homeostasis and metabolism of iron and other metal ions in neurodegenerative diseases.. Signal Transduct Target Ther 10(1):31 PMID: 39894843
- 7. Walke G et al.. 2024. Copper ion incorporation in α-synuclein amyloids.. Protein Sci 33(4):e4956 PMID: 38511511
- 8. Ohse VA et al.. 2024. Copper Homeostasis in the Model Organism C. elegans.. Cells 13(9) PMID: 38727263
